From January 1, 2022 to March 31, 2022, the company has repurchased 1,161,938 shares, representing 4.34% for $5.18 million. With this, the company has completed the repurchase of 1,931,014 shares, representing 7.13% for $8.56 million under the buyback announced on November 17, 2021.
La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+23.73% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |